CYP1B1 and prostate adenocarcinoma: To further examine the effect of CYP1B1 on PCa progression, we analyzed CYP1B1High (n = 50) and CYP1B1Low (n = 50) available prostate adenocarcinoma (PRAD) samples in the TCGA dataset.